STEPHEN A BRUNTON
- Type
- Physician · Allopathic & Osteopathic Physicians / Family Medicine
- Where
- WINNSBORO, SC
- NPI
- 1134116957
- Received
- $1,299,779 in 1,630 records, 2019 to 2025
- As principal investigator
- $417 of research payments to others in 1 record
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 128 | $115,604 |
| 2024 | General payment | 298 | $226,798 |
| 2023 | General payment | 284 | $183,603 |
| 2022 | General payment | 269 | $209,973 |
| 2021 | General payment | 217 | $191,962 |
| 2020 | General payment | 145 | $168,389 |
| 2019 | General payment | 289 | $203,448 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 512 | $682,402 |
| Consulting Fee | 193 | $428,593 |
| Travel and Lodging | 377 | $132,092 |
| Food and Beverage | 524 | $26,217 |
| Compensation for serving as faculty or as a speaker for a medical education program | 9 | $16,812 |
| Honoraria | 3 | $9,585 |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing | 1 | $2,550 |
| Education | 11 | $1,526 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-19 | Abbott Laboratories | $1,275 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-19 | Abbott Laboratories | $1,275 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-19 | Abbott Laboratories | $1,275 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-19 | Abbott Laboratories | $1,168 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-19 | Abbott Laboratories | $589 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-19 | Abbott Laboratories | $589 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-19 | Abbott Laboratories | $67 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-19 | Abbott Laboratories | $67 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-19 | Abbott Laboratories | $61 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-19 | Abbott Laboratories | $42 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-19 | Abbott Laboratories | $42 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-19 | Abbott Laboratories | $25 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-12-10 | Astellas Pharma Global Development | $22 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-12-04 | Novo Nordisk Inc | $49 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-11-26 | Eli Lilly and Company | $450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-11-18 | Lilly USA, LLC | $450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-11-14 | Eli Lilly and Company | $2,475 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-11-14 | Eli Lilly and Company | $1,575 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-11-12 | AstraZeneca Pharmaceuticals LP | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BREZTRI Drug, Respiratory | 2025 | |
| 2025-11-08 | Eli Lilly and Company | $183 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-11-08 | Eli Lilly and Company | $170 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-11-07 | GENZYME CORPORATION | $2,625 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-11-05 | Dexcom, Inc. | $36 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-11-04 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TRULICITY Drug, Diabetes | 2025 | |
| 2025-10-31 | Abbott Laboratories | $4,250 | Consulting Fee | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-31 | Lilly USA, LLC | $3,600 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-31 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-10-31 | Lilly USA, LLC | $1,575 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-31 | Lilly USA, LLC | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-10-23 | AstraZeneca Pharmaceuticals LP | $1,250 | Consulting Fee | Cash or cash equivalent | BREZTRI Drug, Respiratory | 2025 | |
| 2025-10-23 | Lilly USA, LLC | $732 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-10-22 | Abbott Laboratories | $4,000 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE Device, Diabetes Care | 2025 | |
| 2025-10-18 | Abbott Laboratories | $737 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-18 | Abbott Laboratories | $696 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-18 | Abbott Laboratories | $45 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-18 | Abbott Laboratories | $45 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-16 | Abbott Laboratories | $179 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-16 | Abbott Laboratories | $79 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-16 | Abbott Laboratories | $48 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-16 | Abbott Laboratories | $48 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-16 | Abbott Laboratories | $35 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-16 | Abbott Laboratories | $25 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-16 | Abbott Laboratories | $21 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-15 | Abbott Laboratories | $801 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-15 | Abbott Laboratories | $251 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-15 | Abbott Laboratories | $147 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-15 | Abbott Laboratories | $9 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-08 | Abbott Laboratories | $411 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-08 | Abbott Laboratories | $45 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-08 | Abbott Laboratories | $9 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-07 | Abbott Laboratories | $1,109 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-07 | Abbott Laboratories | $159 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-07 | Abbott Laboratories | $45 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-10-07 | Abbott Laboratories | $45 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-09-25 | AstraZeneca Pharmaceuticals LP | $750 | Consulting Fee | Cash or cash equivalent | BREZTRI Drug, Respiratory | 2025 | |
| 2025-09-24 | Insulet Corporation | $1,756 | Consulting Fee | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-09-05 | Abbott Laboratories | $318 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-09-02 | Dexcom, Inc. | $36 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-08-27 | Insulet Corporation | $1,756 | Consulting Fee | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-08-20 | Astellas Pharma Global Development | $24 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-08-18 | AstraZeneca Pharmaceuticals LP | $1,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AIRSUPRA Drug, Respiratory | 2025 | |
| 2025-07-17 | Ferring Pharmaceuticals AS | $2,205 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-07-01 | AstraZeneca Pharmaceuticals LP | $1,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AIRSUPRA Drug, Respiratory | 2025 | |
| 2025-06-22 | Bayer Healthcare Pharmaceuticals Inc. | $34 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-06-21 | Novo Nordisk Inc | $15 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-20 | IDORSIA PHARMACEUTICALS US INC | $104 | Food and Beverage | In-kind items and services | Tryvio Drug, Hypertension | 2025 | |
| 2025-06-03 | AstraZeneca UK Limited | $1,250 | Consulting Fee | Cash or cash equivalent | AIRSUPRA Drug, Respiratory | 2025 | |
| 2025-06-03 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-05-28 | AstraZeneca Pharmaceuticals LP | $1,000 | Consulting Fee | Cash or cash equivalent | AIRSUPRA Drug, Respiratory | 2025 | |
| 2025-05-28 | GlaxoSmithKline, LLC. | $24 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-05-27 | Phathom Pharmaceuticals, Inc. | $99 | Travel and Lodging | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-05-27 | Abbott Laboratories | $16 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-05-21 | AstraZeneca Pharmaceuticals LP | $450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AIRSUPRA Drug, Respiratory | 2025 | |
| 2025-05-16 | AstraZeneca Pharmaceuticals LP | $805 | Consulting Fee | Cash or cash equivalent | BREZTRI Drug, Respiratory | 2025 | |
| 2025-05-12 | AstraZeneca UK Limited | $800 | Consulting Fee | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-05-12 | Lilly USA, LLC | $112 | Travel and Lodging | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-05-12 | Lilly USA, LLC | $7 | Food and Beverage | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-05-07 | Novo Nordisk Inc | $11,626 | Consulting Fee | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-07 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-05-07 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-05-07 | Lilly USA, LLC | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-05-07 | Novo Nordisk Inc | $752 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-07 | Novo Nordisk Inc | $566 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-07 | Novo Nordisk Inc | $508 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-07 | Novo Nordisk Inc | $502 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-07 | Novo Nordisk Inc | $89 | Travel and Lodging | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-06 | Novo Nordisk Inc | $1,310 | Consulting Fee | Cash or cash equivalent | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-02 | Lilly USA, LLC | $29 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-05-02 | Lilly USA, LLC | $19 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-05-01 | AstraZeneca Pharmaceuticals LP | $1,000 | Consulting Fee | Cash or cash equivalent | BREZTRI Drug, Respiratory | 2025 | |
| 2025-04-30 | Abbott Laboratories | $6,800 | Consulting Fee | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-04-30 | Phathom Pharmaceuticals, Inc. | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-04-23 | Phathom Pharmaceuticals, Inc. | $84 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-04-22 | AstraZeneca Pharmaceuticals LP | $1,800 | Consulting Fee | Cash or cash equivalent | FLUMIST QUADRIVALENT Biological, Respiratory | 2025 | |
| 2025-04-02 | Dexcom, Inc. | $31 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-04-01 | Lilly USA, LLC | $117 | Travel and Lodging | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-04-01 | Lilly USA, LLC | $42 | Food and Beverage | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-03-29 | Abbott Laboratories | $139 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-03-29 | Abbott Laboratories | $70 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-03-29 | Abbott Laboratories | $51 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-03-29 | Abbott Laboratories | $49 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-03-28 | Abbott Laboratories | $712 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-03-28 | Abbott Laboratories | $200 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-03-28 | Abbott Laboratories | $176 | Travel and Lodging | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-03-28 | Abbott Laboratories | $139 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-03-28 | Abbott Laboratories | $78 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-03-28 | Abbott Laboratories | $53 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-03-27 | Eli Lilly and Company | $1,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-03-24 | Lilly USA, LLC | $93 | Food and Beverage | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-03-24 | Lilly USA, LLC | $93 | Travel and Lodging | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-03-24 | Lilly USA, LLC | $91 | Travel and Lodging | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-03-24 | Lilly USA, LLC | $35 | Food and Beverage | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-03-20 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-03-20 | Lilly USA, LLC | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-03-19 | Lilly USA, LLC | $29 | Food and Beverage | In-kind items and services | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-03-18 | Lilly USA, LLC | $13 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-03-13 | Lilly USA, LLC | $450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-03-07 | AstraZeneca Pharmaceuticals LP | $1,500 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-02-28 | Lilly USA, LLC | $3,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-02-24 | AstraZeneca Pharmaceuticals LP | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-02-21 | Lilly USA, LLC | $718 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-02-18 | AstraZeneca Pharmaceuticals LP | $1,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-02-18 | AstraZeneca Pharmaceuticals LP | $450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AIRSUPRA Drug, Respiratory | 2025 | |
| 2025-01-17 | AstraZeneca Pharmaceuticals LP | $7,000 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-01-16 | AstraZeneca Pharmaceuticals LP | $8,000 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-01-13 | AstraZeneca Pharmaceuticals LP | $224 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-01-13 | AstraZeneca Pharmaceuticals LP | $104 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-01-13 | AstraZeneca Pharmaceuticals LP | $87 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2024-12-23 | AstraZeneca Pharmaceuticals LP | $2,125 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-12-16 | Dexcom, Inc. | $32 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2024 | |
| 2024-11-21 | Boehringer Ingelheim International GmbH | $1,035 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-11-19 | AstraZeneca Pharmaceuticals LP | $4,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BREZTRI Drug, Respiratory | 2024 | |
| 2024-11-18 | AstraZeneca Pharmaceuticals LP | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-11-14 | AstraZeneca Pharmaceuticals LP | $1,000 | Consulting Fee | Cash or cash equivalent | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-11-11 | AstraZeneca Pharmaceuticals LP | $1,000 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-11-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | $159 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-11-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | $103 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-10-31 | Boehringer Ingelheim Pharmaceuticals, Inc. | $271 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-10-31 | Boehringer Ingelheim Pharmaceuticals, Inc. | $115 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-10-31 | Boehringer Ingelheim Pharmaceuticals, Inc. | $64 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-10-31 | Boehringer Ingelheim Pharmaceuticals, Inc. | $54 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-10-31 | Boehringer Ingelheim Pharmaceuticals, Inc. | $43 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-10-31 | Boehringer Ingelheim Pharmaceuticals, Inc. | $43 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-10-28 | Abbott Laboratories | $4,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FREESTYLE LIBRE Device, Diabetes Care | 2024 | |
| 2024-10-22 | Dexcom, Inc. | $32 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2024 | |
| 2024-10-17 | AstraZeneca Pharmaceuticals LP | $403 | Travel and Lodging | In-kind items and services | BREZTRI Drug, Respiratory | 2024 | |
| 2024-10-17 | AstraZeneca Pharmaceuticals LP | $296 | Travel and Lodging | In-kind items and services | BREZTRI Drug, Respiratory | 2024 | |
| 2024-10-17 | AstraZeneca Pharmaceuticals LP | $296 | Travel and Lodging | In-kind items and services | BREZTRI Drug, Respiratory | 2024 | |
| 2024-10-17 | AstraZeneca Pharmaceuticals LP | $289 | Travel and Lodging | In-kind items and services | BREZTRI Drug, Respiratory | 2024 | |
| 2024-10-17 | AstraZeneca Pharmaceuticals LP | $90 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2024 | |
| 2024-10-17 | AstraZeneca Pharmaceuticals LP | $74 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2024 | |
| 2024-10-17 | AstraZeneca Pharmaceuticals LP | $23 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2024 | |
| 2024-10-16 | AstraZeneca Pharmaceuticals LP | $93 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-10-14 | AstraZeneca Pharmaceuticals LP | $4,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-10-11 | Eli Lilly and Company | $3,150 | Consulting Fee | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-10-11 | Eli Lilly and Company | $1,225 | Consulting Fee | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-10-04 | AstraZeneca Pharmaceuticals LP | $4,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-10-01 | AstraZeneca Pharmaceuticals LP | $1,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-09-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | $4,230 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | STIOLTO RESPIMAT Drug, RESPIRATORY | 2024 | |
| 2024-09-26 | AstraZeneca Pharmaceuticals LP | $618 | Travel and Lodging | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-09-21 | SANOFI-AVENTIS U.S. LLC | $6,902 | Consulting Fee | Cash or cash equivalent | TZIELD Biological, Endocrine & Metabolic Diseases | 2024 | |
| 2024-09-21 | SANOFI-AVENTIS U.S. LLC | $584 | Travel and Lodging | In-kind items and services | TZIELD Biological, Endocrine & Metabolic Diseases | 2024 | |
| 2024-09-21 | SANOFI-AVENTIS U.S. LLC | $490 | Travel and Lodging | In-kind items and services | TZIELD Biological, Endocrine & Metabolic Diseases | 2024 | |
| 2024-09-21 | SANOFI-AVENTIS U.S. LLC | $292 | Food and Beverage | In-kind items and services | TZIELD Biological, Endocrine & Metabolic Diseases | 2024 | |
| 2024-09-21 | SANOFI-AVENTIS U.S. LLC | $140 | Travel and Lodging | In-kind items and services | TZIELD Biological, Endocrine & Metabolic Diseases | 2024 | |
| 2024-09-19 | Bayer Healthcare Pharmaceuticals Inc. | $16 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-09-18 | Boehringer Ingelheim Pharmaceuticals, Inc. | $577 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-09-18 | Phathom Pharmaceuticals, Inc. | $215 | Travel and Lodging | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-09-18 | Phathom Pharmaceuticals, Inc. | $24 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-09-13 | AstraZeneca Pharmaceuticals LP | $720 | Travel and Lodging | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-09-05 | Phathom Pharmaceuticals, Inc. | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-08-29 | Phathom Pharmaceuticals, Inc. | $127 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-08-28 | Phathom Pharmaceuticals, Inc. | $138 | Travel and Lodging | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-08-21 | Phathom Pharmaceuticals, Inc. | $3,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-08-21 | Phathom Pharmaceuticals, Inc. | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-08-16 | Eli Lilly and Company | $5,062 | Consulting Fee | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2024 | |
| 2024-08-16 | Eli Lilly and Company | $1,575 | Consulting Fee | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2024 | |
| 2024-08-15 | AstraZeneca Pharmaceuticals LP | $20 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-08-14 | Phathom Pharmaceuticals, Inc. | $1,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-08-14 | Phathom Pharmaceuticals, Inc. | $93 | Travel and Lodging | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-08-13 | Phathom Pharmaceuticals, Inc. | $175 | Travel and Lodging | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-08-13 | Phathom Pharmaceuticals, Inc. | $120 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-08-13 | Dexcom, Inc. | $32 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2024 | |
| 2024-08-09 | Eli Lilly and Company | $585 | Travel and Lodging | In-kind items and services | 2024 | ||
| 2024-08-07 | Phathom Pharmaceuticals, Inc. | $1,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-08-06 | Eli Lilly and Company | $1,400 | Consulting Fee | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-07-31 | Phathom Pharmaceuticals, Inc. | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-07-25 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-07-23 | Phathom Pharmaceuticals, Inc. | $211 | Travel and Lodging | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-07-23 | Phathom Pharmaceuticals, Inc. | $93 | Food and Beverage | In-kind items and services | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-07-12 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-07-12 | Lilly USA, LLC | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-07-12 | AstraZeneca Pharmaceuticals LP | $1,000 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-07-10 | Lilly USA, LLC | $20 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-07-03 | IDORSIA PHARMACEUTICALS US INC | $1,820 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Tryvio Drug, Hypertension | 2024 | |
| 2024-07-03 | Phathom Pharmaceuticals, Inc. | $1,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VOQUEZNA Drug, GASTROENTEROLOGY | 2024 | |
| 2024-07-01 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-07-01 | Lilly USA, LLC | $81 | Travel and Lodging | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-07-01 | Lilly USA, LLC | $11 | Food and Beverage | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-06-27 | AstraZeneca UK Limited | $2,900 | Consulting Fee | Cash or cash equivalent | 2024 |
The latest 200 records of 1,630.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2022-10-19 | Abbott Laboratories | ILLINOIS ACADEMY OF FAMILY PHYSICIAN | $417 | Sensor Wear Experiences | 2022 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Winnsboro, SC, county Fairfield County, SC, state South Carolina; placed by its city name.
| Measure | Place (city or town) Winnsboro, SC | County Fairfield County, SC | State South Carolina |
|---|---|---|---|
| Population B01003 | 3,322 | 20,550 | 5,296,225 |
| Population, 2020 census P1 | 3,215 | 20,948 | 5,118,425 |
| Median age B01002 | 39.3 | 47.4 | 40.2 |
| Under 18 B01001 | 25.6% | 18.0% | 21.4% |
| 65 and over B01001 | 17.8% | 24.0% | 18.9% |
| Households B11001 | 1,435 | 8,930 | 2,117,989 |
| Foreign born B05002 | 1.2% | 1.1% | 5.8% |
| Median household income B19013 | $37,434 | $47,885 | $69,324 |
| Median family income B19113 | $39,533 | $64,138 | $86,707 |
| Per capita income B19301 | $22,349 | $31,810 | $39,236 |
| Poverty rate B17001 | 12.8% | 15.6% | 14.1% |
| Unemployment rate B23025 | 7.7% | 5.5% | 4.9% |
| Civilian labor force B23025 | 1,589 | 9,657 | 2,560,429 |
| Mean commute (minutes) B08013 | 26.2 | 30.0 | 25.6 |
| Bachelor's degree or higher B15003 | 16.5% | 15.2% | 32.1% |
| Housing units B25001 | 1,798 | 11,003 | 2,443,039 |
| Owner-occupied B25003 | 50.6% | 74.6% | 71.9% |
| Renters B25003 | 49.4% | 25.4% | 28.1% |
| Median home value B25077 | $132,400 | $151,200 | $259,000 |
| Median gross rent B25064 | $856 | $938 | $1,180 |
| White, not Hispanic B03002 | 29.6% | 38.9% | 61.9% |
| Black B03002 | 66.6% | 54.5% | 24.6% |
| Hispanic or Latino B03002 | 2.8% | 2.5% | 7.4% |
| Asian B03002 | 0.0% | 0.1% | 1.7% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Winnsboro, SC.
Comments